Latest News by Industry
The Swiss drugmaker Novartis said it is resuming business in Ukraine after assessing the safety of operating in the nation that Russia invaded in February.
“After studying current safety protocols in the country, and on advice which we will regularly review, we have begun to resume business operations remotely to help the war-torn country restore some basic critical business processes,” Novartis said in a statement.
“The safety and security of our people remain our number one objective, and we will constantly review the situation and our business operations in Ukraine,” the drugmaker said.
Novartis said till date it supplied over 1.3 million packs of antibiotics, painkillers, cardiovascular, and cancer medicines, totaling more than $ 33 million in medical aid.
This is on top of a $ 3 million donation to NGOs that help refugees and displaced persons in Ukraine and neighboring countries.
Picture Credits: Reuters
Also read: